fosaprepitant
Generic: fosaprepitant
Labeler: northstar rx llcDrug Facts
Product Profile
Brand Name
fosaprepitant
Generic Name
fosaprepitant
Labeler
northstar rx llc
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
Active Ingredients
fosaprepitant dimeglumine 150 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
72603-450
Product ID
72603-450_bf207918-100d-4917-88b0-3433c0e72249
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA209965
Listing Expiration
2026-12-31
Marketing Start
2019-09-05
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
72603450
Hyphenated Format
72603-450
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
fosaprepitant (source: ndc)
Generic Name
fosaprepitant (source: ndc)
Application Number
ANDA209965 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 150 mg/5mL
Packaging
- 1 VIAL, SINGLE-DOSE in 1 CARTON (72603-450-01) / 5 mL in 1 VIAL, SINGLE-DOSE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "bf207918-100d-4917-88b0-3433c0e72249", "openfda": {"upc": ["0372603450019"], "unii": ["D35FM8T64X"], "rxcui": ["1731077"], "spl_set_id": ["bf207918-100d-4917-88b0-3433c0e72249"], "manufacturer_name": ["Northstar Rx LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (72603-450-01) / 5 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "72603-450-01", "marketing_start_date": "20250401"}], "brand_name": "Fosaprepitant", "product_id": "72603-450_bf207918-100d-4917-88b0-3433c0e72249", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "72603-450", "generic_name": "Fosaprepitant", "labeler_name": "Northstar Rx LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fosaprepitant", "active_ingredients": [{"name": "FOSAPREPITANT DIMEGLUMINE", "strength": "150 mg/5mL"}], "application_number": "ANDA209965", "marketing_category": "ANDA", "marketing_start_date": "20190905", "listing_expiration_date": "20261231"}